Literature DB >> 15891027

Characterization of a molt-inhibiting hormone (MIH) receptor in the Y-organ of the kuruma prawn, Marsupenaeus japonicus.

Hideaki Asazuma1, Shinji Nagata, Hidekazu Katayama, Tsuyoshi Ohira, Hiromichi Nagasawa.   

Abstract

To characterize a receptor for molt-inhibiting hormone (MIH) in the kuruma prawn, Marsupenaeus japonicus, we performed a binding assay and chemical cross-linking experiments using radiolabeled recombinant MIH ([(125)I]rMIH). The specific binding of [(125)I]rMIH was found in the membrane fraction of the Y-organ (K(d) = 4.76 x 10(-10) M and B(max) = 5.51 x 10(-12) M). Chemical cross-linking between [(125)I]rMIH and the membrane fraction of the Y-organ revealed that the MIH receptor protein has a molecular size of approximately 70 kDa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891027     DOI: 10.1196/annals.1327.027

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Identification and characterization of receptors for ion transport peptide (ITP) and ITP-like (ITPL) in the silkworm Bombyx mori.

Authors:  Chiaki Nagai; Hideaki Mabashi-Asazuma; Hiromichi Nagasawa; Shinji Nagata
Journal:  J Biol Chem       Date:  2014-10-02       Impact factor: 5.157

2.  Neuropeptide action in insects and crustaceans.

Authors:  Donald L Mykles; Michael E Adams; Gerd Gäde; Angela B Lange; Heather G Marco; Ian Orchard
Journal:  Physiol Biochem Zool       Date:  2010 Sep-Oct       Impact factor: 2.247

3.  Molt-inhibiting hormone stimulates vitellogenesis at advanced ovarian developmental stages in the female blue crab, Callinectes sapidus 2: novel specific binding sites in hepatopancreas and cAMP as a second messenger.

Authors:  Nilli Zmora; Amir Sagi; Yonathan Zohar; J Sook Chung
Journal:  Saline Systems       Date:  2009-07-07

Review 4.  The Crustacean Hyperglycemic Hormone Superfamily: Progress Made in the Past Decade.

Authors:  Hsiang-Yin Chen; Jean-Yves Toullec; Chi-Ying Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.